An interventional cardiologist and a tenured associate professor of medicine at the University of Miami Miller School of Medicine. He attended medical school at Universidad Nacional de Tucumán in Argentina. He did his medicine/cardiology training at Hospital Italiano de Buenos Aires in Argentina and subsequently did an interventional cardiology and clinical research fellowship at Duke University Medical Center and the Duke Clinical Research University.
In 2000, he joined the interventional cardiology staff at Hospital Italiano de Buenos Aires, one of the leading medical institutions in South America and also worked as a clinical trials reviewer for ANMAT (Administración Nacional de Medicamentos, Alimentos y TecnologÃas Médicas – National Administration for Medicines, Foods and Medical Technologies) between 2000 and 2002.
In 2003, he joined the Division of Cardiology at the University of North Carolina at Chapel Hill, where he was part of the interventional faculty and the director of cardiology clinical trials. Dr. Cohen is currently the director of the Cardiac Catheterization Laboratory at the University of Miami Hospital. He conducted a multicenter phase IIa multicenter clinical trial and acted as a local PI in more than 10 multi- and single-center clinical trials.
In 2011, he received the “Stop Heart Disease Researcher of the Year Award†by the Florida Heart Research Institute. The Society for Cardiac Angiography and Interventions recognized Dr. Cohen as an “emerging leader†in the field of interventional cardiology. Dr. Cohen has published more than 60 papers in peer-reviewed journals. His major clinical and research interests include novel antithrombotic strategies, transradial cardiac catheterization and intervention, transcatheter valve therapies, and health disparities. He is an established national and international leader in transradial catheterization and interventions.
